mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.08 |
mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.08 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.09 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |